ANURAS
1 call
Concalls & earnings callsAnupam Rasayan India Limited
Every summarised call, newest first. Latest is Q1 FY27, held 14 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Anupam Rasayan began FY27 with strong 36% revenue growth, driven by new product commercialization and the strategic integration of acquisitions to build a diversified specialty chemicals platform.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Consolidated Total Income | ₹668 Cr | 36% | |
| Revenue from Operations | ₹655 Cr | — | |
| Consolidated EBITDA | ₹175 Cr | 35% | |
| EBITDA Margin | 26% | — |
Latest guidance
- Polymer business to be 20-25% on standalone basis and 30-35% on consolidated basis.
- Standalone EBITDA margin guidance: 24-26%.
- Consolidated EBITDA margin guidance: 22-24%.
- Organic revenue growth expected to be 25% plus/minus a couple of percentage points.
- Jayhawk to add 10-15% to revenue growth.
- Cumulative signed LOIs and contracts represent roughly INR18,000 crores of potential business over their respective tenures.
- Working capital expected to improve in coming quarters.
Said on the Q1 FY27 call.
Filed results
Reported quarterly history
From filed quarterly results. YoY and QoQ compare each metric on the same accounting basis.
| Quarter | Revenue | Net profit (PAT) | Basic EPS |
|---|---|---|---|
| Q3 FY25 | ₹390.14 Cr+32% YoY+32.7% QoQ | ₹54.21 Cr+108.3% YoY+77% QoQ | ₹2.57+51.2% YoY+70.2% QoQ |
| Q2 FY25 | ₹293.96 Cr-25% YoY+15.6% QoQ | ₹30.62 Cr-37.1% YoY+150.8% QoQ | ₹1.51-60.1% YoY+319.4% QoQ |
| Q1 FY25 | ₹254.20 Cr-34.2% YoY-36.6% QoQ | ₹12.21 Cr-76.6% YoY-69.8% QoQ | ₹0.36-92.6% YoY-87.2% QoQ |
| Q4 FY24 | ₹401.01 Cr-16.4% YoY+35.7% QoQ | ₹40.47 Cr-44.3% YoY+55.5% QoQ | ₹2.81-59.9% YoY+65.3% QoQ |
| Q3 FY24 | ₹295.52 Cr-22.8% YoY-24.6% QoQ | ₹26.02 Cr-52.2% YoY-46.6% QoQ | ₹1.70-68% YoY-55% QoQ |
Call history
- Q1 FY27Positive tone
Anupam Rasayan began FY27 with strong 36% revenue growth, driven by new product commercialization and the strategic integration of acquisitions to build a diversified specialty chemicals platform.
- Consolidated Total Income
- ₹668 Cr36%
- Revenue from Operations
- ₹655 Cr